[go: up one dir, main page]

GT200600202AA - PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS - Google Patents

PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS

Info

Publication number
GT200600202AA
GT200600202AA GT200600202AK GT200600202K GT200600202AA GT 200600202A A GT200600202A A GT 200600202AA GT 200600202A K GT200600202A K GT 200600202AK GT 200600202 K GT200600202 K GT 200600202K GT 200600202A A GT200600202A A GT 200600202AA
Authority
GT
Guatemala
Prior art keywords
synthesis
organic compounds
methyl
bencenamine
pyrimidil
Prior art date
Application number
GT200600202AK
Other languages
Spanish (es)
Inventor
Stephan Abel
Murat Acemoglu
Bernhard Erb
Christoph Krell
Joseph Sclafani
Mark Meisenbach
Mahavir Prashad
Wen-Chung Shieh
Song Xue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37149980&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600202A(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200600202AA publication Critical patent/GT200600202AA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

LA PRESENTE INVENCIÓN PROPORCIONA UNA MANERA EFICIENTE, SEGURA Y EFECTIVA POR EL COSTO, PARA PREPARAR 5-(4-METIL -1H-IMIDAZOL-1-IL)-3- (TRIFLUORO-METIL)-BENCENAMINA, QUE ES UN INTERMEDIARIO CLAVE PARA LA PREPARACIÓN DE PIRIMIDIL-AMINO-BENZAMIDAS SUSTITUIDAS DE LA FÓRMULA IITHIS INVENTION PROVIDES AN EFFICIENT, SAFE AND EFFECTIVE WAY FOR THE COST, TO PREPARE 5- (4-METHYL -1H-IMIDAZOL-1-IL) -3- (TRIFLUORO-METHYL) -BENCENAMINE, WHICH IS A KEY INTERMEDIARY FOR PREPARATION OF PYRIMIDIL-AMINO-BENZAMIDES REPLACED OF FORMULA II

GT200600202AK 2005-06-09 2012-05-17 PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS GT200600202AA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68897605P 2005-06-09 2005-06-09

Publications (1)

Publication Number Publication Date
GT200600202AA true GT200600202AA (en) 2014-06-09

Family

ID=37149980

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600202AK GT200600202AA (en) 2005-06-09 2012-05-17 PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS

Country Status (25)

Country Link
US (2) US7781597B2 (en)
EP (3) EP2292607B1 (en)
JP (2) JP5225078B2 (en)
KR (2) KR101249199B1 (en)
CN (6) CN102174021B (en)
AR (1) AR057056A1 (en)
AT (1) ATE540931T1 (en)
AU (3) AU2006258050B2 (en)
BR (1) BRPI0611683A2 (en)
CA (4) CA2942046A1 (en)
DK (2) DK2266961T3 (en)
ES (3) ES2465522T3 (en)
GT (1) GT200600202AA (en)
HU (1) HUE028024T2 (en)
IN (2) IN2014DN08588A (en)
JO (1) JO2758B1 (en)
MX (1) MX2007015609A (en)
MY (1) MY146795A (en)
PE (3) PE20100715A1 (en)
PL (3) PL2266961T3 (en)
PT (3) PT2292607E (en)
RU (1) RU2446162C2 (en)
SI (2) SI2266961T1 (en)
TW (1) TWI380981B (en)
WO (1) WO2006135640A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1930136B (en) 2004-03-05 2012-02-08 日产化学工业株式会社 Isoxazoline substituted benzamide compound and pest control agent
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds
TW200803740A (en) 2005-12-16 2008-01-16 Du Pont 5-aryl isoxazolines for controlling invertebrate pests
TWI412322B (en) 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
BRPI0809770B8 (en) 2007-06-13 2022-12-06 Du Pont COMPOUND AND COMPOSITION TO CONTROL AN INVERTEBRATE PEST
TWI430995B (en) 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
DK2957284T3 (en) 2007-06-27 2018-02-05 Du Pont PROCEDURE TO CHECK ANIMALS FOR ANIMALS
TWI600639B (en) 2007-08-17 2017-10-01 杜邦股份有限公司 Compound for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
KR20100075996A (en) 2007-10-03 2010-07-05 이 아이 듀폰 디 네모아 앤드 캄파니 Naphthalene isoxazoline compounds for control of invertebrate pests
TWI583664B (en) 2008-04-09 2017-05-21 杜邦股份有限公司 Carbonyl compound and preparation method thereof
US20100016590A1 (en) * 2008-07-17 2010-01-21 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
EP2530081A3 (en) 2008-11-05 2013-04-10 Teva Pharmaceutical Industries, Ltd. Nilotinib HCI crystalline forms
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
US20110053968A1 (en) 2009-06-09 2011-03-03 Auspex Pharmaceuticals, Inc. Aminopyrimidine inhibitors of tyrosine kinase
MX2012013758A (en) 2010-05-27 2013-01-24 Du Pont Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4, 5 - dihydro - 5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [ ( 2, 2, 2 - trifluoroethyl) amino] ethyl] -1- naphthalenecarboxamide.
BR112014015720B1 (en) 2011-12-30 2020-03-17 Hanmi Pharm. Co., Ltd. TIENO DERIVATIVES [3,2-D] PYRIMIDIN, PHARMACEUTICAL COMPOSITION AND USE OF THEM FOR THE PREVENTION OR TREATMENT OF A DISEASE CAUSED BY ABNORMAL ACTIVATION OF A KINASE PROTEIN
CN102592837B (en) * 2012-03-12 2014-01-15 河北师范大学 Method for preparing polyaniline electrode doped with tetrachloride metal quaternary ammonium salt for supercapacitor
CN103694176B (en) * 2014-01-07 2015-02-18 苏州立新制药有限公司 Preparation method of nilotinib intermediate
CN104592122B (en) * 2014-12-09 2018-01-23 凯莱英医药集团（天津）股份有限公司 The preparation method of 3 (base of 4 methyl 1H imidazoles 1) 5 (trifluoromethyl) aniline
CN105985293B (en) * 2015-03-04 2018-04-03 埃斯特维华义制药有限公司 The preparation method of AMN107 intermediate
EP3095782A1 (en) 2015-05-18 2016-11-23 Esteve Química, S.A. New method for preparing 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CN107201532B (en) * 2017-05-09 2019-08-27 吉林凯莱英医药化学有限公司 The nitration method of aromatic compound
WO2019130254A1 (en) * 2018-01-01 2019-07-04 Laurus Labs Ltd An improved process for 3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl) aniline
CN108530364B (en) * 2018-04-10 2020-01-21 江苏创诺制药有限公司 Crystal form of 3- (4-methyl-1H-imidazole-1-yl) -5-trifluoromethyl aniline monohydrochloride and application thereof
EP3806858A4 (en) 2018-06-15 2022-03-09 Handa Pharmaceuticals, Inc. SALTS OF KINASE INHIBITORS AND ASSOCIATED COMPOSITIONS
US11014945B2 (en) * 2019-04-06 2021-05-25 Trinapco, Inc. Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same
EP3904342A1 (en) 2020-04-28 2021-11-03 Grindeks, A Joint Stock Company Process for the preparation of 3-(trifluoromethyl)-5-(4-methyl-1h-imidazole-1-yl)-benzeneamine hydrochloride
CN114751836B (en) * 2021-02-23 2024-05-31 四川青木制药有限公司 Synthesis method and intermediate of 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline
CN114853734A (en) * 2022-06-14 2022-08-05 海南鑫开源医药科技有限公司 A kind of preparation method of Nilotinib free base
CN116478319B (en) * 2022-11-07 2025-07-01 华北电力大学 Preparation method of an ionic covalent organic polymer and its application in adsorbing ReO4- in an alkaline environment
CN115626880B (en) * 2022-11-15 2023-11-14 常州大学 Synthesis method of 3-nitro-5-cyano benzotrifluoride
CN118108670B (en) * 2023-12-28 2025-07-01 江苏希迪制药有限公司 Purification method of nilotinib intermediate 3- (4-methyl-1H-imidazol-1-yl) -5- (trifluoromethyl) aniline

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1051076A1 (en) * 1982-04-09 1983-10-30 Алтайский политехнический институт Process for preparing imidazole derivatives
CA1292234C (en) * 1984-05-29 1991-11-19 Simon Fraser Campbell Heterocyclic-substituted quinolone inotropic agents
GB8413685D0 (en) * 1984-05-29 1984-07-04 Pfizer Ltd Quinolone inotropic agents
GB8502267D0 (en) * 1985-01-30 1985-02-27 Pfizer Ltd Quinolone inotropic agents
HN2001000008A (en) * 2000-01-21 2003-12-11 Inc Agouron Pharmaceuticals AMIDA COMPOSITE AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THE INSTRUCTIONS FOR USE
GB0023383D0 (en) * 2000-09-23 2000-11-08 Synprotec Ltd 3,5-Bis (Trifluormethyl)Benzene derivatives
PE20040522A1 (en) * 2002-05-29 2004-09-28 Novartis Ag DIARYLUREA DERIVATIVES DEPENDENT ON PROTEIN KINASE
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
GB0222514D0 (en) 2002-09-27 2002-11-06 Novartis Ag Organic compounds
CN1939910A (en) * 2004-12-31 2007-04-04 孙飘扬 Amino-metadiazine compound and its salt, its preparation and pharmaceutical use
GT200600207A (en) * 2005-06-09 2007-01-15 Novartis Ag PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS
MY146795A (en) * 2005-06-09 2012-09-28 Novartis Ag Process for the synthesis of organic compounds

Also Published As

Publication number Publication date
HUE028024T2 (en) 2016-11-28
CN102174020A (en) 2011-09-07
ES2558696T3 (en) 2016-02-08
PT1896426E (en) 2012-04-12
CN102180796A (en) 2011-09-14
MX2007015609A (en) 2008-02-25
PE20070109A1 (en) 2007-04-02
PL2266961T3 (en) 2016-04-29
AU2006258050B2 (en) 2010-12-09
CN102174021B (en) 2013-02-27
US7781597B2 (en) 2010-08-24
KR101249199B1 (en) 2013-04-03
CA2611280A1 (en) 2006-12-21
JP5225078B2 (en) 2013-07-03
TW200716563A (en) 2007-05-01
RU2446162C2 (en) 2012-03-27
JP2013035855A (en) 2013-02-21
SI2292607T1 (en) 2014-09-30
CN102180836A (en) 2011-09-14
US20080200692A1 (en) 2008-08-21
PE20100715A1 (en) 2010-10-25
SI2266961T1 (en) 2016-02-29
EP2292607A3 (en) 2011-04-27
JO2758B1 (en) 2014-03-15
ATE540931T1 (en) 2012-01-15
PL1896426T3 (en) 2012-06-29
PE20100716A1 (en) 2010-10-25
CN102174019A (en) 2011-09-07
ES2380489T8 (en) 2012-06-22
CN102174021A (en) 2011-09-07
EP2266961A2 (en) 2010-12-29
ES2380489T3 (en) 2012-05-14
TWI380981B (en) 2013-01-01
US8008504B2 (en) 2011-08-30
WO2006135640A3 (en) 2007-08-02
DK2292607T3 (en) 2014-06-30
EP1896426A2 (en) 2008-03-12
US20100280257A1 (en) 2010-11-04
PT2266961E (en) 2016-02-05
AU2011201044A1 (en) 2011-03-31
CA2611280C (en) 2014-01-28
AU2010241374A1 (en) 2010-12-02
EP2292607A2 (en) 2011-03-09
AU2010241374B2 (en) 2011-11-03
IN2014DN08588A (en) 2015-07-10
IN2014DN08578A (en) 2015-07-10
CN101189212B (en) 2011-05-18
CA2942046A1 (en) 2006-12-21
AU2006258050A1 (en) 2006-12-21
CN102174020B (en) 2012-11-07
KR20080014010A (en) 2008-02-13
EP2292607B1 (en) 2014-04-09
PL2292607T3 (en) 2014-09-30
EP2266961A3 (en) 2011-07-27
KR20120099028A (en) 2012-09-06
EP2266961B1 (en) 2015-10-21
EP1896426B1 (en) 2012-01-11
DK2266961T3 (en) 2016-01-25
CA2886482A1 (en) 2006-12-21
KR101283109B1 (en) 2013-07-05
ES2465522T3 (en) 2014-06-06
CA2886482C (en) 2017-09-05
CA2833394C (en) 2016-03-29
WO2006135640A2 (en) 2006-12-21
RU2007148238A (en) 2009-07-20
CN102174019B (en) 2013-02-13
PT2292607E (en) 2014-06-24
MY146795A (en) 2012-09-28
BRPI0611683A2 (en) 2010-09-28
CA2833394A1 (en) 2006-12-21
CN101189212A (en) 2008-05-28
CN102180836B (en) 2012-11-21
AR057056A1 (en) 2007-11-14
JP2008546645A (en) 2008-12-25

Similar Documents

Publication Publication Date Title
GT200600202AA (en) PROCESS FOR THE SYNTHESIS OF ORGANIC COMPOUNDS
SV2011003809A (en) HETEROARILO DERIVATIVES AS DGAT1 INHIBITORS
CR9830A (en) AMINO-5- [4- (DIFLUOROMETOXI) PHENYL] -5-PHENYLIMIDAZOLONE COMPOUNDS FOR THE INHIBITION OF B-SECRETASE
ATE555105T1 (en) HETEROCYCLIC FXR BINDING COMPOUNDS
SV2008003045A (en) AMINOTETRAHYDROPIRANS AS DIPERTIDIL INHIBITORS, PEPTIDASE-IV FOR THE TREATMENT OR PREVENTION OF DIABETES
CR9331A (en) VEGF-R2 INHIBITORS AND METHODS
GT200600009A (en) AMINO-IMIDAZOLONAS FOR THE INHIBITION OF BETA-SECRETASA
PA8772701A1 (en) "AMINO-5 COMPOUNDS - [- 4- (DIFLUOROMETOXI) REPLACED PHENYL) -5-PHENYLIMIDAZOLONE AS INHIBITORS OF ß-SECRETASE"
MX2008002293A (en) Novel use of peptide compounds for treating muscle pain.
JO2848B1 (en) Organic Compounds
NI201100081A (en) AMINOTETRAHYDROPYRANS AS INHIBITORS OF DIPEPTIDIL PEPTIDASE - IV FOR THE TREATMENT OR PREVENTION OF DIABETES.
DOP2011000113A (en) PIRAZOLILAMINOPIRIDINAS AS FAK INHIBITORS
GT200800242A (en) BICYCLE DERIVATIVES AS CETP INHIBITORS
NO20085029L (en) Substituted pyridylamide compounds as modulators of the histamine H3 receptor
NO20081685L (en) Process for the preparation of oxazolidine protection aminodol compounds useful as intermediates for Florfenicol
HN2010000313A (en) FUSIONED BICYCLE PYRIMIDINS
MX2010004669A (en) Preparation of dihydropyrrol derivatives as intermediates.
UY30778A1 (en) COMPOUNDS OF 5,6-DIHIDRO-1H-PIRIDIN-2-ONA
ATE517869T1 (en) PRODUCTION OF SUBSTITUTED MORPHINAN-6-ONE AND SALTS AND INTERMEDIATE PRODUCTS THEREOF
CU23820A3 (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND OBTAINING PROCEDURE
PA8782301A1 (en) IMPACT RESISTANT LEUKEMIA TREATMENT
NO20090234L (en) Tricyclic composition and pharmaceutical use thereof
DOP2006000175A (en) CONDENSED 1,4-DIHYDROPIRIDINE HETEROCICLES, PROCESSES TO PREPARE THE SAME, USE AND COMPOSITIONS CONTAINING THEM
EA200971003A1 (en) BICYCLIC COMPOUND AND ITS PHARMACEUTICAL APPLICATION
GT200500311A (en) ORGANIC COMPOUNDS